Expression levels of serum secreted frizzled-related protein 5, heat shock protein 60 and solute carrier family 16 member 11 in patients with gestational diabetes mellitus and their relationships with insulin resistance

WEI Man; YUAN Wenhe; LIU Hongyun; MA Dimeng; YAN Kanglu; HAN Ning

doi:10.7619/jcmp.20242397

Journal of Clinical Medicine in Practice > 2024 > 28(20): 60-65. > DOI: 10.7619/jcmp.20242397

WEI Man, YUAN Wenhe, LIU Hongyun, MA Dimeng, YAN Kanglu, HAN Ning. Expression levels of serum secreted frizzled-related protein 5, heat shock protein 60 and solute carrier family 16 member 11 in patients with gestational diabetes mellitus and their relationships with insulin resistance[J]. Journal of Clinical Medicine in Practice, 2024, 28(20): 60-65. DOI: 10.7619/jcmp.20242397

Citation:

PDF (1052 KB)

Expression levels of serum secreted frizzled-related protein 5, heat shock protein 60 and solute carrier family 16 member 11 in patients with gestational diabetes mellitus and their relationships with insulin resistance

Department of Obstetrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 457001

More Information

Received Date: June 05, 2024
Revised Date: September 10, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the expression levels of secreted frizzled-related protein 5 (sFRP5), heat shock protein 60 (HSP60) and solute carrier family 16 member 11 (SLC16A11) in serum of patients with gestational diabetes mellitus (GDM) and their relationships with insulin resistance.
Methods
A total of 120 GDM patients in the hospital from January 2022 to December 2023 were selected as study group, and another 120 healthy pregnant women in the same period were selected as control group. The expression levels of serum sFRP5, HSP60 and SLC16A11 were detected; the levels of insulin resistance-related indicators[fasting blood glucose (FBG), fasting insulin (FINS), and homeostasis model assessment of insulin resistance (HOMA-IR)]were measured and calculated; the Pearson's correlation method was used to analyze the correlations of serum sFRP5, HSP60 and SLC16A11 with insulin resistance; the Logistic regression andysis and receiver operating characteristic (ROC) curve analysis were used to assess the relationships of serum sFRP5, HSP60 and SLC16A11 with GDM.
Results
The serum sFRP5 expression in the study group was significantly lower than that in the control group, while the serum HSP60, SLC16A11, FBG, FINS and HOMA-IR levels were significantly higher than those in the control group (P < 0.05). Pearson's correlation analysis showed that serum sFRP5 was negatively correlated with HSP60, SLC16A11, FBG, FINS and HOMA-IR (P < 0.05); serum HSP60 was positively correlated with SLC16A11, FBG, FINS and HOMA-IR (P < 0.05); serum SLC16A11 was positively correlated with FBG, FINS and HOMA-IR (P < 0.05). Multivariate Logistic regression analysis revealed that HSP60, SLC16A11, FBG, FINS and HOMA-IR were risk factors for GDM in pregnant patients, while sFRP5 was a protective factor (P < 0.05). The area under the curve (AUC) for the combined diagnosis of GDM in pregnant patients by serum sFRP5, HSP60 and SLC16A11 was 0.924, indicating that the combined diagnostic value of three indicators was superior to that of each individual indicator (all P < 0.05).
Conclusion
GDM patients exhibit decreased serum sFRP5 level and increased HSP60 and SLC16A11 levels; three indicators are factors influencing the occurrence of GDM in pregnant patients, and are associated with insulin resistance; the combination of three indicators exhibits high diagnostic efficacy for GDM.

FullText(HTML)

References (25)

References

[1]	YE W R, LUO C, HUANG J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis[J]. BMJ, 2022, 377: e067946.
[2]	HILDÉN K, HANSON U, PERSSON M, et al. Gestational diabetes and adiposity are independent risk factors for perinatal outcomes: a population based cohort study in Sweden[J]. Diabet Med, 2019, 36(2): 151-157. doi: 10.1111/dme.13843
[3]	ZHANG Y H, CHEN Y Y, QU H M, et al. Methylation of HIF3A promoter CpG islands contributes to insulin resistance in gestational diabetes mellitus[J]. Mol Genet Genomic Med, 2019, 7(4): e00583. doi: 10.1002/mgg3.583
[4]	SERT U Y, OZGU-ERDINC A S. Gestational diabetes mellitus screening and diagnosis[J]. Adv Exp Med Biol, 2021, 1307: 231-255.
[5]	LI Y, TIAN M Y, YANG M L, et al. Central Sfrp5 regulates hepatic glucose flux and VLDL-triglyceride secretion[J]. Metabolism, 2020, 103: 154029. doi: 10.1016/j.metabol.2019.154029
[6]	朱伟, 郑世霞, 柯琳秋, 等. SFRP5对小鼠肝癌细胞系Hepa1-6糖代谢的影响[J]. 基础医学与临床, 2018, 38(9): 1268-1273.
[7]	ZHANG D L, LIU H, ZHANG Y M, et al. Heat shock protein 60 (HSP60) modulates adiponectin signaling by stabilizing adiponectin receptor[J]. Cell Commun Signal, 2020, 18(1): 60. doi: 10.1186/s12964-020-00546-5
[8]	WU X X, GUO J Y, CHEN Y L, et al. The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells[J]. Br J Haematol, 2020, 190(5): 741-752. doi: 10.1111/bjh.16569
[9]	HIDALGO B A, SOFER T, QI Q B, et al. Associations between SLC16A11 variants and diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)[J]. Sci Rep, 2019, 9(1): 843. doi: 10.1038/s41598-018-35707-7
[10]	中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J]. 中华妇产科杂志, 2014, 49(8): 561-569.
[11]	XIE J W, LI L, XING H Y. Metabolomics in gestational diabetes mellitus: a review[J]. Clin Chim Acta, 2023, 539: 134-143. doi: 10.1016/j.cca.2022.12.005
[12]	DŁUSKI D F, WOLINSKA E, SKRZYPCZAK M. Epigenetic changes in gestational diabetes mellitus[J]. Int J Mol Sci, 2021, 22(14): 7649. doi: 10.3390/ijms22147649
[13]	JOHNS E C, DENISON F C, NORMAN J E, et al. Gestationaldiabetes mellitus: mechanisms, treatment, and complications[J]. Trends Endocrinol Metab, 2018, 29(11): 743-754. doi: 10.1016/j.tem.2018.09.004
[14]	王志强, 吴剑华, 庄伟, 等. 利拉鲁肽对耐克罗米芬多囊卵巢综合征患者氧化应激, 胰岛素抵抗及血清SFRP5, IL-34水平的影响[J]. 中国妇产科临床杂志, 2023, 24(3): 307-309.
[15]	姜瑞丰, 施妙君, 鄢巨振. 维持性血液透析患者血清Shp5、Klotho水平变化及其与钙磷代谢的关系[J]. 广东医学, 2020, 41(2): 152-155.
[16]	刘敏, 缪华珍. GDM患者miRNA-125b、SFRP5、SerpinBl变化及益生菌联合胰岛素治疗效果[J]. 中国计划生育杂志, 2023, 31(10): 2354-2358.
[17]	方云艳, 秦雯, 王小蓓, 等. 血清sFRP5与老年2型糖尿病患者视网膜病变的相关性[J]. 国际检验医学杂志, 2023, 44(21): 2602-2606.
[18]	刘莉芳, 赵桁, 张云良, 等. 2型糖尿病患者血清Nesfatin-1、HSP60与下肢血管病变的相关性研究[J]. 中国动脉硬化杂志, 2021, 29(11): 965-970.
[19]	马聆桦, 李江恒, 钟柳育, 等. 高龄孕产妇临床特征及孕检对妊娠风险的影响[J]. 实用临床医药杂志, 2022, 26(9): 50-53. doi: 10.7619/jcmp.20214722
[20]	TIMOFEEV Y S, KISELEV A R, DZHIOEVA O N, et al. Heat shock proteins (HSPs) and cardiovascular complications of obesity: searching for potential biomarkers[J]. Curr Issues Mol Biol, 2023, 45(12): 9378-9389. doi: 10.3390/cimb45120588
[21]	ALUKSANASUWAN S, SUEKSAKIT K, FONG-NGERN K, et al. Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress[J]. FASEB J, 2017, 31(5): 2157-2167. doi: 10.1096/fj.201600910RR
[22]	ZIMBONE S, DI ROSA M C, CHIECHIO S, et al. Exploring the role of Hsp60 in Alzheimer's disease and type 2 diabetes: suggestion for common drug targeting[J]. Int J Mol Sci, 2023, 24(15): 12456. doi: 10.3390/ijms241512456
[23]	张坦, 漆正堂, 丁树哲. SLC16A11调控小鼠骨骼肌Akt/GLUT4通路的研究及运动对SLC16A11和GLUT4表达的影响[J]. 中国运动医学杂志, 2022, 41(1): 43-51.
[24]	THILAK S, RAJENDRA A, GANESH V. Association of obesity and insulin resistance to gestational diabetes mellitus[J]. Bioinformation, 2023, 19(2): 211-214. doi: 10.6026/97320630019211
[25]	陈辰, 陈亚军, 戴楠, 等. 妊娠期糖尿病患者孕早期糖脂代谢状态的研究[J]. 中国妇幼保健, 2018, 33(15): 3445-3447.

[1]	SHEN Xiaofang, JIN Jin, ZHANG Lan, YANG Lingli, XU Ji. Application value of prediction model established based on limb muscle strength status combined with clinical data for occurrence of deep vein thrombosis in acute stage of stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 113-117. DOI: 10.7619/jcmp.20221968
[2]	GAO Guangchuan, WEI Chunyan, KUANG Jianhua. Changes of immune and inflammation related indexes in children with Kawasaki disease at acute stageand their relationships with prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 24-27. DOI: 10.7619/jcmp.20210984
[3]	AN Xuefang, TANG Siyuan, LIN Bailang, LIU Cuixia, LIN Haili. Effect of professional nurses-dominated rehabilitation management mode for acute stroke patients[J]. Journal of Clinical Medicine in Practice, 2017, (22): 16-18,25. DOI: 10.7619/jcmp.201722006
[4]	ZHANG Jingyi, LIANG Di, PANG Jing. Clinical study on statin therapy and dose selection in treatment of patients with acute coronary syndrome in acute stage[J]. Journal of Clinical Medicine in Practice, 2017, (5): 18-21. DOI: 10.7619/jcmp.201705005
[5]	WANG Cuiyun. Effect comparison of routine care and predictive nursing mode in patients with acute cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2016, (12): 14-16. DOI: 10.7619/jcmp.201612005
[6]	XIA Yan, XU Yan, JI Niu. Nursing evaluation of three phases and ten steps method in clinical prognosis of patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2016, (8): 8-10. DOI: 10.7619/jcmp.201608003
[7]	XU Yan, WANG Xia, HU Wei, HU Xiaoyan. Influence of phased rehabilitation nursing on quality of life of patients with acute stroke[J]. Journal of Clinical Medicine in Practice, 2015, (8): 12-14. DOI: 10.7619/jcmp.201508004
[8]	YANG Min. Efficacy and safety of single sialic acid ganglion glycosides ester in the treatment of acute cerebral hemorrhage[J]. Journal of Clinical Medicine in Practice, 2013, (16): 61-62,67. DOI: 10.7619/jcmp.201316022
[9]	LV Guoling, HUO Zhenglu. Study on the levels and influencing factors of serum cystatin C, homocysteine and acute phase C reactive protein in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (11): 12-14. DOI: 10.7619/jcmp.201311004
[10]	YANG Li-sun, CHEN Fei, WANG Yi-peng, SHAO Zhen-yu. A Clinical Study on Nutritional Support in Patients with Acute Severe Head Injury[J]. Journal of Clinical Medicine in Practice, 2007, (11): 35-38. DOI: 10.3969/j.issn.1672-2353.2007.11.010

Cited By

Cited by

Periodical cited type(17)

1.	林荫，赖珏，林春燕，李佳. 文拉法辛联合氟西汀对伴焦虑症状重度抑郁症患者的效果. 西北药学杂志. 2024(02): 200-205 .
2.	马东丽，罗加国，蒋丹，黄堂辉，陈岗. 喹硫平联合丙戊酸钠对精神分裂症急性发作期患者的疗效和安全性评价. 中国药物应用与监测. 2024(03): 256-259 .
3.	王平贵，邓睿，李丹. 氟西汀联合奥氮平治疗重度抑郁症患者的疗效. 中国药物应用与监测. 2024(05): 601-604 .
4.	王芳，张君奇. 酸枣仁汤联合文拉法辛治疗抑郁伴失眠临床观察. 实用中医药杂志. 2023(10): 2019-2021 .
5.	吕燕霞，王丽娟，王萍，邵菊美. 喹硫平缓释片治疗精神分裂症的临床效果. 中国现代医生. 2022(01): 17-20 .
6.	孙妍，林冬梅. 小剂量奥氮平联合文拉法辛对重度抑郁症急性期患者疗效的影响. 中国当代医药. 2022(07): 57-59+63 .
7.	闫志新，刘欣. 文拉法辛联合奥氮平对产后抑郁患者生活质量焦虑情绪的影响. 中国妇幼保健. 2022(16): 2914-2917 .
8.	班春霞，孟美玲，倪章春，于伟霞，王湖，陈翔春，汪崇泽. 高频重复经颅磁刺激在抑郁症急性期患者治疗中的增效作用. 新乡医学院学报. 2022(11): 1055-1059 .
9.	朱永，刘颖. 阿戈美拉汀与文拉法辛治疗抑郁症的临床效果比较. 中国现代医生. 2021(01): 95-98 .
10.	孙雨锋，韦宇霞，韦中阳，邢晶伟. 文拉法辛对老年骨质疏松性椎体压缩骨折患者心理健康状况的影响. 国际精神病学杂志. 2021(01): 128-130+134 .
11.	朱永，刘颖. 艾司西酞普兰与文拉法辛治疗老年焦虑症的疗效及安全性比较. 中国现代医生. 2021(07): 22-25 .
12.	石奇嵩. 文拉法辛联合喹硫平治疗重度抑郁症急性期的效果及对患者血清BDNF、Cor表达的影响. 中国医学创新. 2021(13): 139-142 .
13.	刘洋，李静. 文拉法辛联合普瑞巴林治疗躯体形式疼痛障碍抑郁症的效果. 当代医学. 2021(22): 147-149 .
14.	王飞飞. 文拉法辛联合喹硫平治疗双相情感障碍的临床效果探讨. 中外医疗. 2021(24): 95-97 .
15.	苗琴，潘苗，张美霞，张志勇，张蒙蒙，许彤，张瑞岭. 文拉法辛和帕罗西汀对伴发焦虑的女性抑郁症患者的疗效. 国际精神病学杂志. 2021(06): 1007-1010 .
16.	肖桃，黄善情，谢焕山，陈宏镇，于东港，卢浩扬，王占璋，张明，尚德为，温预关. 喹硫平联合文拉法辛对文拉法辛及O-去甲基文拉法辛血药浓度的影响. 中国临床药理学杂志. 2020(18): 2785-2787+2794 .
17.	于亮，王桂英，曲蕃升. 文拉法辛与舍曲林治疗首发抑郁症的效果和药理分析. 中国医药指南. 2020(35): 39-40 .

Other cited types(1)

Get Citation

PDF

XML

Article views (97) PDF downloads (7) Cited by(18)

Turn off MathJax

Article Contents

Abstract

References

Expression levels of serum secreted frizzled-related protein 5, heat shock protein 60 and solute carrier family 16 member 11 in patients with gestational diabetes mellitus and their relationships with insulin resistance